AR123435A1 - Derivados de sulfamoil urea que contienen resto alquilo-oxacicloalquilo, y usos de los mismos - Google Patents
Derivados de sulfamoil urea que contienen resto alquilo-oxacicloalquilo, y usos de los mismosInfo
- Publication number
- AR123435A1 AR123435A1 ARP210102472A ARP210102472A AR123435A1 AR 123435 A1 AR123435 A1 AR 123435A1 AR P210102472 A ARP210102472 A AR P210102472A AR P210102472 A ARP210102472 A AR P210102472A AR 123435 A1 AR123435 A1 AR 123435A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- moiety
- independently
- formula
- oxacycloalky
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074521P | 2020-09-04 | 2020-09-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR123435A1 true AR123435A1 (es) | 2022-11-30 |
Family
ID=77951864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210102472A AR123435A1 (es) | 2020-09-04 | 2021-09-03 | Derivados de sulfamoil urea que contienen resto alquilo-oxacicloalquilo, y usos de los mismos |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240043410A1 (enExample) |
| EP (1) | EP4208459A1 (enExample) |
| JP (1) | JP7865948B2 (enExample) |
| KR (1) | KR20230061505A (enExample) |
| CN (1) | CN116783184A (enExample) |
| AR (1) | AR123435A1 (enExample) |
| AU (1) | AU2021336518B2 (enExample) |
| BR (1) | BR112023003792A2 (enExample) |
| CA (1) | CA3191410A1 (enExample) |
| IL (1) | IL301055A (enExample) |
| MX (1) | MX2023002686A (enExample) |
| TW (1) | TWI916398B (enExample) |
| WO (1) | WO2022051582A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| HUE067378T2 (hu) | 2019-06-12 | 2024-10-28 | Nodthera Ltd | Szulfonilurea származékok és alkalmazásaik |
| JP7661248B2 (ja) | 2019-06-12 | 2025-04-14 | ノッドセラ リミテッド | スルホニル尿素誘導体及びその使用 |
| KR20260115622A (ko) * | 2023-11-17 | 2026-07-24 | 노드테라 리미티드 | 우레아 유도체의 제조 방법 |
| CN122555701A (zh) | 2023-11-17 | 2026-08-11 | 诺瑟拉有限公司 | 脲衍生物的形式和相关用途 |
| TW202545527A (zh) * | 2024-01-16 | 2025-12-01 | 英商諾得瑟拉公司 | Nlrp3及glp-1a組合療法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| DK1270565T3 (da) | 1997-01-29 | 2004-10-04 | Pfizer | 4-substitueret furan-2-sulfonamid og dets anvendelse i fremstillingen af sulfonylurinstofderivater |
| JP6929792B2 (ja) * | 2015-02-16 | 2021-09-01 | ザ ユニバーシティ オブ クィーンズランド | スルホニル尿素及び関連化合物並びにその使用 |
| JP7412328B2 (ja) | 2017-07-24 | 2024-01-12 | ノバルティス アーゲー | Nlrp活性に関連する状態を治療するための化合物及び組成物 |
| GB201721185D0 (en) * | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| SG11202101480XA (en) | 2018-08-15 | 2021-03-30 | Inflazome Ltd | Novel sulfonamideurea compounds |
-
2021
- 2021-09-03 JP JP2023514910A patent/JP7865948B2/ja active Active
- 2021-09-03 EP EP21778667.2A patent/EP4208459A1/en active Pending
- 2021-09-03 MX MX2023002686A patent/MX2023002686A/es unknown
- 2021-09-03 WO PCT/US2021/049001 patent/WO2022051582A1/en not_active Ceased
- 2021-09-03 CA CA3191410A patent/CA3191410A1/en active Pending
- 2021-09-03 CN CN202180074301.7A patent/CN116783184A/zh active Pending
- 2021-09-03 KR KR1020237011396A patent/KR20230061505A/ko active Pending
- 2021-09-03 AU AU2021336518A patent/AU2021336518B2/en active Active
- 2021-09-03 US US18/043,883 patent/US20240043410A1/en active Pending
- 2021-09-03 AR ARP210102472A patent/AR123435A1/es unknown
- 2021-09-03 IL IL301055A patent/IL301055A/en unknown
- 2021-09-03 TW TW110132880A patent/TWI916398B/zh active
- 2021-09-03 BR BR112023003792A patent/BR112023003792A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL301055A (en) | 2023-05-01 |
| CA3191410A1 (en) | 2022-03-10 |
| TWI916398B (zh) | 2026-03-01 |
| BR112023003792A2 (pt) | 2023-03-28 |
| AU2021336518A1 (en) | 2023-03-23 |
| EP4208459A1 (en) | 2023-07-12 |
| AU2021336518B2 (en) | 2026-05-21 |
| MX2023002686A (es) | 2023-04-03 |
| JP2023540733A (ja) | 2023-09-26 |
| US20240043410A1 (en) | 2024-02-08 |
| KR20230061505A (ko) | 2023-05-08 |
| JP7865948B2 (ja) | 2026-05-26 |
| WO2022051582A1 (en) | 2022-03-10 |
| TW202229265A (zh) | 2022-08-01 |
| CN116783184A (zh) | 2023-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR114941A1 (es) | Derivados de sulfonilurea | |
| AR126351A1 (es) | Compuestos y sus sales inhibidores del inflamasoma nlrp3 | |
| AR119698A2 (es) | Compuesto amida n-urea sustituida derivado de aminoácido | |
| AR117616A1 (es) | Compuestos anti-vih | |
| AR110139A1 (es) | COMPUESTOS MONO Y ESPIROCÍCLICOS QUE CONTIENEN CICLOBUTANO Y AZETIDINA COMO INHIBIDORES DE LA INTEGRINA aV | |
| PE20181272A1 (es) | Heterociclilaminas como inhibidores de pi3k | |
| AR089865A1 (es) | Derivados de bencimidazol e imidazopiridinas como moduladores de canales de sodio | |
| AR095279A1 (es) | N-(4-(azaindazol-6-il)-fenil)-sulfonamidas y su uso como productos farmacéuticos | |
| AR104513A1 (es) | Derivados de ciclohexano sustituidos con amidas como inhibidores de tnks1 y/o tnks2 | |
| AR066331A1 (es) | Piridonacarboxamidas agentes protectores de plantas utiles que contienen a estas y procedimientos para su preparacion y su utilizacion | |
| AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
| AR097862A1 (es) | Inhibidores de tirosina quinasa de bruton | |
| AR067060A1 (es) | Derivados de guanina policiclicos y sus metodos de uso | |
| AR096979A1 (es) | Derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| AR100806A1 (es) | Inhibidores de fosfatidilinositol 3-quinasa | |
| AR088828A1 (es) | DERIVADOS DE CICLOHEXILAMINA QUE TIENEN ACTIVIDAD COMO AGONISTAS ADRENERGICOS b2 Y COMO ANTAGONISTAS MUSCARINICOS M3 | |
| AR092288A1 (es) | Ligandos del receptor ep1 | |
| AR118521A1 (es) | Compuestos y composiciones farmacéuticas de los mismos para el tratamiento de trastornos inflamatorios | |
| AR097199A1 (es) | Inhibidores de rorc2 y sus métodos de uso | |
| AR108387A1 (es) | Compuestos de tipo tetrahidropirimidodiazepina y dihidropiridodiazepina para tratar el dolor y afecciones relacionadas con el dolor | |
| PE20240691A1 (es) | Compuestos moduladores de gcn2 y usos de los mismos | |
| AR116905A1 (es) | Derivados de ácido pirrolidino-2-carboxílico para tratar el dolor y afecciones relacionadas con el dolor | |
| AR030562A1 (es) | Derivados de dibenzoazuleno, su uso y procedimientos para prepararlos. | |
| PE20181328A1 (es) | Compuestos de dihidroquinolinsulfonamida de alquilo | |
| AR134040A1 (es) | Moduladores de mrgprx2 y métodos de tratamiento relacionados |